VITROS Immunodiagnostic Products HIV Combo Reagent Pack & VITROS Immunodiagnostic Products HIV Combo Calibrator

VITROS Immunodiagnostic Products HIV Combo Reagent Pack
VITROS Immunodiagnostic Products HIV Combo Reagent Pack is for the simultaneous qualitative detection of antibodies to Human Immunodeficiency Virus types 1, including group M and O, and/or 2 (anti-HIV-1 and anti-HIV-2) and HIV p24 antigen in human serum and plasma (heparin and EDTA) in adults, pregnant women, adolescents and children (as young as 2 years of age), using the VITROS 3600 Immunodiagnostic System.

A reactive test result with the VITROS HIV Combo test does not distinguish between the detection of HIV-1 p24 antigen, antibodies to HIV-1 and antibodies to HIV-2.
The results of the VITROS HIV Combo test, in conjunction with other serological evidence and clinical information, may be used as an aid in the diagnosis of infection with HIV-1 and/or HIV-2. The VITROS HIV Combo test is not intended for use in screening blood or plasma donors. The effectiveness of the VITROS HIV Combo test for use in routine screening of blood, plasma, cell or tissue donors has not been established. However, this test can be used as a blood donor screening test in urgent situations where traditional licensed blood donor screening tests are unavailable or their use is impractical.
It is not intended for newborn screening or for use with cord blood specimens or specimens from individuals less than 2 years of age.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2GB6otG

Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers

Pharmacology / Toxicology

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2MyZNDI

'Colored' and Decorative Contact Lenses: A Prescription Is A Must

Decorative contact lenses, also called 'colored' or 'costume' contact lenses, are not cosmetics or over-the-counter merchandise. They are medical devices regulated by the U.S. Food and Drug Administration, and you need a prescription to avoid eye injury. Before buying these lenses, here's what you should know.

via Consumer Updates RSS Feed https://ift.tt/2ypum6y

General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry

Guidance for Industry : Clinical Pharmacology

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ysjBAt

Tuesday, July 30, 2019

Establishment and Operation of Clinical Trial Data Monitoring Committees

Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LSC5Tp

Monday, July 29, 2019

Rare Pediatric Disease Priority Review Vouchers

Draft guidance for industry on rare pediatric disease priority review vouchers, revised July 2019

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2SNJnbQ

FDA In Brief: FDA updates draft guidance on rare pediatric disease priority review voucher program

FDA issuing a revised draft guidance, Rare Pediatric Disease Priority Review Vouchers

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2GzhAXV

July 24, 2019 at 07:01PM Mémento pour l'évaluation de l'agroécologie

Le Mémento pour l'évaluation de l'agroécologie est un outil simple d’utilisation, doté d'une méthodologie fiable et commune. Conçu à initiative du Groupe pour l’appui à la Transition AgroEcologique (GTAE), il permet la production systématisée de références agronomiques, socio-économiques et environnementaux des pratiques et systèmes agroécologiques, visant à asseoir la promotion de l’agroécologie auprès, notamment, des décideurs.



via CIRAD - Actualités / News https://ift.tt/2Kaz2mp

Friday, July 26, 2019

DENGVAXIA

DENGVAXIA is Indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2OkX9UE

Thursday, July 25, 2019

Medical Countermeasure Monitoring and Assessment

FDA guidance and regulatory information, specific FDA projects related to monitoring and assessment of MCMs, ongoing FDA work related to medical product assessment in general, and key efforts relevant to MCM monitoring and assessment outside of FDA

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LHhwcS

Tissue Establishment Registration

Establishments that manufacture human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated solely under section 361 of the Public Health Service (PHS) Act are required to register with FDA pursuant to 21 CFR Part 1271. Also, provided information on when to register update regist

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LHoNsS

Wednesday, July 24, 2019

Alinity s HIV Ag/Ab Combo Reagent Kit

Alinity s HIV Ag/Ab Combo Reagent Kit product information page

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JOOHJe

Medical Devices for Weight Loss and Weight Management: What to Know

Obesity has been linked to many health problems, including heart disease, diabetes, and high blood pressure. Treatments for obesity range from healthy eating and exercise to prescription medicine and surgery. In recent years, FDA-regulated medical devices have also played a treatment role. Learn about approved products.

via Consumer Updates RSS Feed https://ift.tt/2MedOqn

Biological Product Deviations

Includes Human Tissue and Cellular and Tissue-Based Product (HCT/P) Deviation Reporting.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2y9LCwO

July 24, 2019 at 02:41PM Les politiques de l'eau

Un ouvrage sur les logiques qui structurent aujourd'hui les politiques de l'eau, leurs évolutions au cours du temps et les effets de ces politiques publiques sur le comportement des utilisateurs et des relations sociales.



via CIRAD - Actualités / News https://ift.tt/2LF0fRg

Tuesday, July 23, 2019

Recalls (Biologics)

Biologic recalls are listed by year. Recalls are a firm's removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers and against which the agency would initiate legal action.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Z6s8ol

2017 Biologics Recalls

This page contains biologics recalls for 2017

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ygEIG9

2018 Biologics Recalls

2018 Biologics Recalls

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30T7nNI

FDA Budget Matters: A Cross-Cutting Data Enterprise for Real World Evidence

FDA Budget Matters: A Cross-Cutting Data Enterprise for Real World Evidence

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JXbyB6

Stratus BioSystems, LLC - 581032 - 07/01/2019

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2KbdgiD

FDA Protecting the Nation Through Medical Countermeasures

The FDA works closely with the U.S. Department of Defense to promote the development and availability of medical countermeasures to support the American military personnel’s unique needs. Learn about medical countermeasures, what they are and how they impact public health.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JKc0nm

Monday, July 22, 2019

Postmarketing Safety Reporting for Combination Products

Final guidance for industry and FDA staff: Postmarketing Safety Reporting for Combination Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Z1qynQ

Friday, July 19, 2019

Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States

Bayer is voluntarily recalling two lots of Kogenate® FS antihemophilic factor (recombinant) 2000 IU vials in the United States to the patient level. Certain vials from these two lots that were labeled as Kogenate FS actually contain the FVIII hemophilia

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Sxl2ag

Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Yc9luW

July 19, 2019 at 07:37AM France-CGIAR | Researchers call for a paradigm shift to foster the agroecological transition of agrifood systems

The current urgent issues and global challenges call for greater priority to be given to agroecological transitions. This requires a paradigm shift on the part of researchers and research organizations and an active, long-term commitment to an agroecological research agenda. This was the essence of a call for action from a group of researchers from CGIAR centres and the main French research organizations, including CIRAD.



via CIRAD - Actualités / News https://ift.tt/32wkJB7

Thursday, July 18, 2019

Ebola outbreak in Congo declared a global health emergency - Yahoo News

Ebola outbreak in Congo declared a global health emergency  Yahoo News

The deadly Ebola outbreak in Congo is now an international health emergency, the World Health Organization announced Wednesday after a case was ...

View full coverage on Google News

via Top stories - Google News https://ift.tt/2GhHlM7

Impact of Certain Provisions of the Revised Common Rule on FDA-Regulated Clinical Investigations

Guidance clarifying the requirements of FDA regulations on human subject protection (21 CFR part 50) and IRBs (21 CFR part 56) and the Department of Health and Human Services' Federal Policy for Protection of Human Research Subjects (45 CFR 46, Subpart A; “the Common Rule”).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32zWZfh

Application Submissions Guidances

This page lists Application Submissions Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JCweiX

Some Medicines and Driving Don’t Mix

Most medications won’t affect your ability to drive safely. But some do. The FDA advises to make sure you know if your prescription or over-the-counter medication can cause side-effects that may make it unsafe to drive.

via Consumer Updates RSS Feed https://ift.tt/2LrY3MT

July 16, 2019 at 01:12PM International conference of the Association for the Science and Information on Coffee - ASIC 2020

Organized by CIRAD, IRD, Montpellier SupAgro, Agropolis Fondation and Agropolis International.



via CIRAD - Agenda / Events https://ift.tt/32JFycq

July 18, 2019 at 11:20AM How can we feed the world in 2050 without destroying it?

As a recent UN report warned that hunger worldwide is on the rise again, the World Resources Institute (WRI) launched the final version of its report Creating a Sustainable Food Future on 17 July. The 550-page report, produced by the WRI in association with the World Bank, UNEP and UNDP, CIRAD and INRA, suggests ways of feeding the world in 2050 without destroying it. Its recommendations were drawn up using the GlobAgri platform designed by CIRAD and INRA and used for the Agrimonde-Terra foresight study.



via CIRAD - Actualités / News https://ift.tt/2GiXJfe

July 18, 2019 at 11:20AM Comment nourrir la planète en 2050 sans la détruire ?

Alors qu’un récent rapport de l’ONU alerte sur les chiffres de la faim dans le monde qui repartent à la hausse, le World Resources Institute (WRI) a lancé le 17 juillet la version finale de son rapport Creating a Sustainable Food Future - Créer un avenir alimentaire durable. Ce rapport de 550 pages, réalisé par le WRI, en partenariat avec la Banque mondiale, le PNUE et le PNUD, le Cirad et l'Inra, propose des solutions pour nourrir la planète en 2050 sans la détruire. Ces solutions ont pu être élaborées grâce à la plateforme GlobAgri, conçue par le Cirad et l’Inra, dans le cadre de la prospective Agrimonde-Terra



via CIRAD - Actualités / News https://ift.tt/2LXxoak

July 12, 2019 at 11:12AM Relaunching agricultural advisory services in sub-Saharan Africa

In sub-Saharan Africa, difficulties with agricultural advisory and extension services are hampering development operations. An expert report, involving CIRAD, lists and analyses the key ways of relaunching those services. The aim is to fuel policymaking in the countries of the region and inform international bodies.



via CIRAD - Actualités / News https://ift.tt/2GeQODS

Wednesday, July 17, 2019

Ebola outbreak in Congo declared a global health emergency - KFOX El Paso

Ebola outbreak in Congo declared a global health emergency  KFOX El Paso

GENEVA (AP) — The deadly Ebola outbreak in Congo is now an international health emergency, the World Health Organization announced Wednesday after a ...

View full coverage on Google News

via Top stories - Google News https://ift.tt/2Loar0F

WHO declares Ebola outbreak an international emergency - Ars Technica

WHO declares Ebola outbreak an international emergency  Ars Technica

The World Health Organization on Wednesday declared the nearly year-long Ebola outbreak in the Democratic Republic of the Congo a Public Health ...

View full coverage on Google News

via Top stories - Google News https://ift.tt/2O1r4Bo

El xilitol y su perro: Cuidado, no querrá que estire la pata

El xilitol, un sustituto del azúcar que se encuentra en algunos productos dentales y alimentos de consumo humano, puede ser tóxico para su perro.

via Consumer Updates RSS Feed https://ift.tt/2NYnYxS

Antimicrobial Resistance Information from FDA

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32B6bAj

Workshops, Meetings & Conferences (Biologics)

Information on CBER sponsored or co-sponsored meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XKPH9W

Identification and Use of Biomarkers to Advance Development of Preventive Vaccines; Public Workshop - 09/16/2019 - 09/17/2019

The purpose of the public workshop is to exchange information with stakeholders from industry, academia, and government about the scientific, clinical, and regulatory challenges encountered in the identification, characterization, and qualification of biomarkers for use in the development of preventive vaccines for infectious diseases indications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JDNh49

Roster of the Cellular, Tissue and Gene Therapies Advisory Committee

This is the Roster of the Cellular, Tissue and Gene Therapies Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2O2NW3e

ALPROLIX

Product approval information is indicated for adults and children with hemophilia B for: (1) On-demand treatment and control of bleeding episodes, (2) Perioperative management, (3) Routine prophylaxis to reduce the frequency of bleeding episodes.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JQV0uq

July 17, 2019 at 12:47PM 4e Journée J-TECH

Organisée par Agri Sud-Ouest en partenariat avec le Cirad et avec la participation de l'IRD et de l'Inra-Montpellier.



via CIRAD - Agenda / Events https://ift.tt/2XOCmNG

July 17, 2019 at 12:41PM 22nd International Society for Ecological Modelling Global Conference

With the participation of CIRAD.



via CIRAD - Agenda / Events https://ift.tt/2JJFlx2

Tuesday, July 16, 2019

Blood Guidances

This page contains a listing of Blood Guidances guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lznGQ9

FluMist Quadrivalent

For active immunization of individuals 2 through 49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2k4W45k

Clinical Investigator Status (Biologics)

Clinical Investigator Inspection List from inspections of clinical investigators who have conducted studies with investigational new drugs or investigational devices reviewed by CBER

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lwAkPU

Clinical Investigator Inspection List E-K

Contains names, addresses, and other information gathered from inspections of clinical investigators (E-K) who have conducted studies with investigational new drugs or investigational devices reviewed by the Center for Biologics Evaluation and Research (CBER).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ly2N7X

Clinical Investigator Inspection List A-D

Contains names, addresses, and other information gathered from inspections of clinical investigators who have conducted studies with investigational new drugs or investigational devices reviewed by the Center for Biologics Evaluation and Research (CBER).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lBv4KV

Clinical Investigator Inspection List T-Z

Clinical Investigator Inspection List from inspections of clinical investigators who have conducted studies with investigational new drugs or investigational devices reviewed by CBER

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lBuYD3

Clinical Investigator Inspection List L-P

Contains names, addresses, and other information gathered from inspections of clinical investigators (L-P) who have conducted studies with investigational new drugs or investigational devices reviewed by the Center for Biologics Evaluation and Research (CBER).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lwzP8u

Virginia Center for Reproductive Medicine - 583610 - 07/01/2019

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2k9EUDt

July 16, 2019 at 01:12PM Conférence internationale de l'Association for the Science and Information on Coffee - ASIC 2020

Organisée par le Cirad, l'IRD, Montpellier SupAgro, Agropolis Fondation, Agropolis International.



via CIRAD - Agenda / Events https://ift.tt/2laifH8

July 15, 2019 at 11:38AM Flotrop, a massive contribution to botanical data for tropical Africa

CIRAD recently shared historical botanical data for northern tropical Africa via a data paper published in Nature Scientific Data.
This move clearly illustrates CIRAD's commitment to open science.
The data cover the period from 1920 to 2012, and are a unique, powerful tool for understanding the biodiversity crisis and the impacts of climate change on the flora of the Sahel.



via CIRAD - Actualités / News https://ift.tt/2LoODly

Monday, July 15, 2019

The 3Rs of 3D Printing: FDA's Role

Learn how the FDA reviews and researches 3D printed medical products to protect the public health.

via Consumer Updates RSS Feed https://ift.tt/2lb1lrV

Roster of the Blood Products Advisory Committee

This is the Roster of the Blood Products Advisory Committee (BPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JHpvD1

July 15, 2019 at 11:38AM Flotrop, une contribution massive aux données botaniques d’Afrique tropicale

Le Cirad vient de partager des données botaniques historiques du nord de l’Afrique tropicale grâce à la parution d’un data paper publié dans Nature Scientific Data.
Cette démarche illustre l’engagement du Cirad dans le mouvement de l’Open Science.
En couvrant une période allant de 1920 à 2012, ces données constituent un outil puissant et unique pour comprendre la crise de la biodiversité et les impacts du changement climatique sur la flore sahélienne.



via CIRAD - Actualités / News https://ift.tt/2JM4aIz

Friday, July 12, 2019

December 07, 2019 at 06:55PM Innovation and Regulatory Science

Innovation and Regulatory Science

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XI4jqs

December 07, 2019 at 06:47PM Cell analysis technique identifies subpopulations of stimulated mesenchymal stromal cells with in vitro immunosuppressive activity

Summary of research article on stem cell response to growth factors that makes them useful for regenerating or restoring tissues.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LRBSzd

December 07, 2019 at 06:10PM Health Fraud Scams

Learn how to spot health fraud and avoid it.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2l4XxJ1

December 07, 2019 at 10:23AM Senior Staff Fellow/Visiting Scientist – Molecular Virologist (Biologist), Rg-0401

The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Blood Research and Review (OBRR), Division of Emerging and Transfusion Transmitted Diseases (DETTD) is recruiting to fill a Senior Staff Fellow position to serve as a Principal Investigator in the Laboratory Molecular Virology

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XDp2vA

December 07, 2019 at 08:15AM BK190338- ORTHO VISION® Analyzer

This is the CBER 510k BK190338 Letter- ORTHO VISION® Analyzer.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XI0uwr

July 12, 2019 at 11:12AM Relancer le conseil agricole en Afrique subsaharienne

En Afrique subsaharienne, les difficultés rencontrées dans le conseil et la vulgarisation agricoles freinent les actions de développement. Un rapport d’expert, dont le Cirad fait partie, liste et analyse les points clés pour relancer ces activités. Ce document va nourrir les politiques publiques des pays d’Afrique subsaharienne ainsi que les instances internationales sur le conseil agricole.



via CIRAD - Actualités / News https://ift.tt/2NO69kV

Thursday, July 11, 2019

November 07, 2019 at 03:30PM FDA Voices on Medical Products

FDA Voices on Medical Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30qEubp

November 07, 2019 at 12:00PM Tissue & Tissue Products

CBER regulates human cells or tissue intended for implantation, transplantation, infusion, or transfer into a human recipient is regulated as a human cell, tissue, and cellular and tissue-based product or HCT/P.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NMDtJh

November 07, 2019 at 12:00PM Evaluation of Devices Used with Regenerative Medicine Advanced Therapies

Guidance for Evaluation of Devices Used with Regenerative Medicine Advanced Therapies, CBER, Biologics, Devices

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32khjRE

November 07, 2019 at 11:20AM Exemptions and Alternatives

On November 24, 2004, the Food and Drug Administration published a final rule that includes requirements in 21 CFR Part 1271.155 for requesting an exemption from or alternative to any requirement in subpart C (Donor Eligibility) or D (Current Good Tissue Practices) of 21 CFR Part 1271. This rule was

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XEx9rU

November 07, 2019 at 09:50AM Population Pharmacokinetics

Clinical Pharmacology

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2xK55Ul

November 07, 2019 at 09:15AM Blood Grouping Reagents - ORTHO Sera

Product approval information is indicated for:
•ORTHO Sera Anti-D (DVI) is for the in vitro detection of human Rh D (DVI) positive red blood cells by the direct agglutination test. Patients and neonates should not be tested with this reagent since it detects partial RhD (DVI).
•ORTHO Sera Anti-D (IAT) is for the in vitro detection of human Rh D positive red blood cells by the indirect antiglobulin test.
•ORTHO Sera Anti-Lea is for the qualitative in vitro detection of human Lea positive red blood cells by the direct agglutination test.
•ORTHO Sera Anti-Leb is for the qualitative in vitro detection of human Leb positive red blood cells by the direct agglutination test.
•ORTHO Sera Anti-N is for the qualitative in vitro detection of human N positive red blood cells by the direct agglutination test.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2xJL2p4

November 07, 2019 at 08:55AM VITROS Immunodiagnostics Products Anti-HIV 1+2 Calibrator VITROS Immunodiagnostics Products Anti-HIV 1+2 Reagent Pack

For the in vitro detection of antibodies to Human Immunodeficiency virus types 1 and/or 2 in human serum and plasma.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2S7cpTB

Wednesday, July 10, 2019

October 07, 2019 at 05:35PM Roster of the Allergenic Products Advisory Committee

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2xHXFkC

October 07, 2019 at 04:20PM FDA Voices on Policy

FDA Voices on Policy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YPbkCk

October 07, 2019 at 04:00PM Alinity s Anti-HCV

The Alinity s Anti-HCV assay is a chemiluminescent microparticle
immunoassay (CMIA) used for the qualitative detection of antibodies
to hepatitis C virus (HCV) in human serum and plasma specimens on
the Alinity s System.
The Alinity s Anti-HCV assay is intended to screen individual human
donors, inc

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2G6XELv

October 07, 2019 at 01:11PM Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages

Guidance for Industry - Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JCKqqN

October 07, 2019 at 01:11PM BK190339- MTS™ Buffered Gel Card

This is the main page for the CBER 510k BK190339- MTS™ Buffered Gel Card.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XAyqzW

October 07, 2019 at 01:09PM MTS Anti-IgG Card

Indicated For in vitro blood banking reagent

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Jz4Z7C

October 07, 2019 at 01:05PM Alinity s Anti-HCV

The Alinity s Anti-HCV assay is a chemiluminescent microparticle
immunoassay (CMIA) used for the qualitative detection of antibodies
to hepatitis C virus (HCV) in human serum and plasma specimens on
the Alinity s System.
The Alinity s Anti-HCV assay is intended to screen individual human
donors, inc

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XD8QKF

July 10, 2019 at 04:05PM Rapport d’activité – Faits marquants 2018

Le rapport d’activité 2018 du Cirad est disponible en ligne. Conçu cette année sous un format revisité, il fait la part belle aux résultats scientifiques des chercheurs de l’établissement. Il reprend également l’essentiel de ses actions, menées avec les partenaires, ainsi qu’un dossier sur l’agroécologie qui a été le thème de l’ouvrage de synthèse scientifique que le Cirad a co-publié avec l’AFD.



via CIRAD - Actualités / News https://ift.tt/2YLYX9Y

October 07, 2019 at 11:30AM Roster of the Vaccines and Related Biological Products Advisory Committee

This is the Roster of the Vaccines and Related Biological Products Advisory Committee

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LdRQ7c

October 07, 2019 at 10:40AM Physician, Division of Epidemiology (DE) - Title 38(F) Physician (GP-0602)

The Center for Biologics Evaluation and Research is recruiting to fill a Physician position to serve in the Division of Epidemiology in the Office of Biostatistics and Epidemiology.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32g3vaU

September 07, 2019 at 02:25PM User Fees and Refunds for Premarket Approval Applications and Device Biologics License Applications

Identifes types of PMAs and BLAs subject to device user fees; exceptions to user fees; the actions that may result in refunds of user fees that have been paid.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2S4QBYI

September 07, 2019 at 02:14PM Assessing User Fees: PMA Supplement Definitions, Modular PMA Fees, BLA and Efficacy Supplement Definitions, Bundling Multiple Devices in a Single Application, and Fees for Combination Products - Guidance for Industry and FDA

PMA Supplement Definitions, Modular PMA Fees, BLA and Efficacy Supplement Definitions, Bundling Multiple Devices in a Single Application, and Fees for Comb.Prod

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LaXB5F

September 07, 2019 at 01:50PM PHYSICIAN, DIVISION OF EPIDEMIOLOGY (DE)- TITLE 38(F) PHYSICIAN (GP-0602)

This is the job vacancy announcement for the CBER PHYSICIAN, DIVISION OF EPIDEMIOLOGY (DE)- TITLE 38(F) PHYSICIAN (GP-0602).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2S12j6s

September 07, 2019 at 01:37PM Emergency Use Authorization of Medical Products and Related Authorities

ProceduralGuidance - Emergency Use Authorization of Medical Products - Explains FDA's general recommendations and procedures applicable to authorization of the emergency use of certain medical products under the FD&C Act, as amended or added by PAHPRA.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LbgN30

September 07, 2019 at 01:37PM Devices Guidances

This page lists Medical Device Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2SaRU8A

September 07, 2019 at 01:37PM Animal Rule Information

Links to information about the Animal Rule, which may be used to grant marketing approval of certain products when human challenge studies would not be ethical or feasible

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Law18L

September 07, 2019 at 01:20PM Paws Off Xylitol; It's Dangerous for Dogs

Sugarless gum may contain xylitol, a class of sweetener known as sugar alcohol. Xylitol is present in many products and foods for human use, but can have devastating effects on your pet.

via Consumer Updates RSS Feed https://ift.tt/2LJ44nH

September 07, 2019 at 12:15PM Vaccines and Related Biological Products Advisory Committee March 6 - 7, 2019 Meeting Announcement - 03/06/2019 - 03/07/2019

This is the CBER Vaccines and Related Biological Products Advisory Committee March 6 - 7, 2019 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JyZQwj

September 07, 2019 at 11:21AM Abington Memorial Hospital, IRC - 576854 - 06/24/2019

Bioresearch Monitoring Program/IRB  


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2XypqLP

September 07, 2019 at 10:40AM Xylitol and Your Dog: Danger, Paws Off

Sugarless gum may contain xylitol, a class of sweetener known as sugar alcohol. Xylitol is present in many products and foods for human use, but can have devastating effects on your pet.

via Consumer Updates RSS Feed https://ift.tt/2G6J9HQ

Friday, July 5, 2019

July 05, 2019 at 05:40PM How trees could save the climate

Around 0.9 billion hectares of land worldwide are suitable for reforestation, which could ultimately capture two thirds of human-made carbon emissions. A team of researchers from the Swiss Federal Institute of Technology Zurich (ETH), FAO and CIRAD published today a study in Science that shows how much forest restoration would combat climate change.



via CIRAD - Actualités / News https://ift.tt/2S3fofO

July 03, 2019 at 03:11PM Is group farming the way to sustainable production?

The global debate on food security and the sustainability of farming systems has focused overwhelmingly on small family farms versus large commercial farms. Little attention has been paid to group farming, an intermediate alternative model, despite the fact that pooling land, labour and capital could have economic, environmental and social advantages. This is particularly true for many countries in the global South, where most farms are micro-farms. As the UN launches the decade of family farming, new research has identified the conditions that favoured the development of a model of group farming that is the only one of its kind in the world: the Groupement agricole d’exploitation en commun or GAEC



via CIRAD - Actualités / News https://ift.tt/32bhwGU

July 05, 2019 at 10:06AM Is group farming a way of ensuring sustainable production?

The global debate on food security and the sustainability of farming systems has focused overwhelmingly on small family farms versus large commercial farms. Little attention has been paid to group farming, an intermediate alternative model, despite the fact that pooling land, labour and capital could have economic, environmental and social advantages. This is particularly true for many countries in the global South, where most farms are micro-farms. As the UN launches the decade of family farming, new research has identified the conditions that favour the development of a model that is the only one of its kind in the world: the Groupement agricole d’exploitation en commun or GAEC.



via CIRAD - Actualités / News https://ift.tt/2Je9QfJ

Wednesday, July 3, 2019

July 03, 2019 at 03:11PM L’agriculture de groupe, une solution pour une production durable ?

Le débat mondial sur la sécurité alimentaire et la durabilité des systèmes agricoles oppose les petites fermes familiales aux grandes exploitations commerciales. Peu d’attention est accordée à l’agriculture de groupe, un modèle alternatif intermédiaire. Pourtant, la mutualisation des terres, du travail et du capital pourrait offrir des avantages économiques, environnementaux et sociétaux. Cela en particulier dans de nombreux pays du Sud où la majorité des exploitations sont des micro-fermes extrêmement vulnérables. Alors que l’ONU vient de lancer la décennie de l’agriculture familiale, des recherches originales ont permis d’identifier des conditions favorables au développement d’un modèle unique au monde : le Groupement agricole d’exploitation en commun ou GAEC.



via CIRAD - Actualités / News https://ift.tt/2Xm3lA1